Status:
COMPLETED
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the long-term pulmonary and cardiovascular safety of Exubera in routine clinical practice.
Detailed Description
Pfizer announced in October 2007 that it would stop marketing Exubera. At that time, Pfizer committed to continued marketing until it returned the licensing rights for the technology to Nektar. Follow...
Eligibility Criteria
Inclusion
- Eligible for receiving Exubera treatment based on the approved local label
Exclusion
- Pregnant or lactating
- Have a progressive fatal disease or a life expectancy that prohibits them from participating in a five-year research study
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
1976 Patients enrolled
Trial Details
Trial ID
NCT00359801
Start Date
July 1 2006
End Date
April 1 2009
Last Update
February 2 2010
Active Locations (197)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bay Minette, Alabama, United States, 36507-4185
2
Pfizer Investigational Site
Fairhope, Alabama, United States, 36532
3
Pfizer Investigational Site
Graysville, Alabama, United States, 35073
4
Pfizer Investigational Site
Pell City, Alabama, United States, 35125